A nurse is assessing a client with clinical manifestations associated with scleroderma. The nurse would use what tool to assist with assessment of this client?

Choice A rationale The Hendrich II Fall Risk Model is a clinical assessment tool used to determine a patient's probability of falling based on factors like confusion, symptomatic depression, and altered elimination. While general safety is important, this tool does not address the specific physiological or systemic changes associated with scleroderma. Scleroderma involves the overproduction of collagen, leading to skin thickening and organ dysfunction, which requires specialized diagnostic criteria rather than a general mobility and fall risk assessment. Choice B rationale The Braden Scale is used to predict pressure sore risk by evaluating sensory perception, moisture, activity, mobility, nutrition, and friction. Although scleroderma causes skin changes such as hardening and tightening, the Braden Scale is not the primary tool for assessing the unique vascular and fibrotic manifestations of the disease. While skin integrity is a concern, the nurse must prioritize tools that identify the multi-system involvement and specific diagnostic markers characteristic of this complex autoimmune connective tissue disorder. Choice C rationale The Mini-Cog is a rapid screening tool for cognitive impairment and dementia in older adults, consisting of a three-item recall test and a clock-drawing task. Scleroderma is primarily a physical, systemic autoimmune disease affecting the skin, blood vessels, and internal organs like the lungs and kidneys. Cognitive decline is not a hallmark clinical manifestation of scleroderma. Therefore, using a cognitive screen would not provide the nurse with relevant data regarding the progression or severity of the patient's scleroderma. Choice D rationale CREST is a specific acronym used to assess the limited cutaneous form of systemic sclerosis. It stands for Calcinosis, Raynaud's phenomenon, Esophageal dysfunction, Sclerodactyly, and Telangiectasia. Using this tool allows the nurse to systematically evaluate the classic symptoms of the disease. Identifying these specific clinical markers is essential for monitoring disease progression and managing potential complications like dysphagia or digital ulcers. It is the gold standard clinical framework for bedside assessment of patients with this condition.